首页 › 基金 › BARDIN HILL MANAGEMENT PARTNERS LP › INDV

BARDIN HILL MANAGEMENT PARTNERS LP 对 INDV 的持仓历史

INDIVIOR PHARMACEUTICALS INC · 医疗保健

BARDIN HILL MANAGEMENT PARTNERS LP 在 Q3 2025 的 13F 申报中披露持有 INDV(INDIVIOR PHARMACEUTICALS INC)87,611 股,市值约 US$2.1M,约占其申报组合的 2.63%,在其申报持仓中市值排名第 5 位。 BARDIN HILL MANAGEMENT PARTNERS LP 于 Q3 2025 首次申报该持仓。

最新持仓 (Q3 2025)87.61K 股
申报持仓市值$2.11M
组合权重2.63%
首次申报Q3 2025
最近变动新进
更新于2026-10-18

最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR

BARDIN HILL MANAGEMENT PARTNERS LP 对 INDV 的持仓演变

BARDIN HILL MANAGEMENT PARTNERS LP 于 Q3 2025 首次披露 INDV 持仓:87,611 股(约 US$2.1M)。

逐季持仓明细

季度股数金额变化
Q3 2025 87.61K $2.11M 新进

关于 INDV 与 13F 数据

INDV(INDIVIOR PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 54 只申报持有 INDV,申报仓位最大的包括:OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 INDV 的基金

查看 INDV 的全部基金持有人 →

常见问题

How long has BARDIN HILL MANAGEMENT PARTNERS LP held INDV?

BARDIN HILL MANAGEMENT PARTNERS LP has disclosed INDV holdings in 1 of the last 1 reported quarters, going back to Q3 2025.

What is BARDIN HILL MANAGEMENT PARTNERS LP's current position in INDV?

As of Q3 2025, BARDIN HILL MANAGEMENT PARTNERS LP holds 87.61K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $2.11M, representing 2.63% of its reported portfolio and ranking #5.

Has BARDIN HILL MANAGEMENT PARTNERS LP been buying or selling INDV?

In the latest 13F filing (Q3 2025), BARDIN HILL MANAGEMENT PARTNERS LP newly opened its position in INDV.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.